 | Up a level |
Journal Article
Hahn, M., Buerckert, J-P, Luttenberger, C. A., Klebow, S., Hess, M., Al-Maarri, M., Vogt, M., Reissig, S., Hallek, M., Wienecke-Baldacchino, A., Buch, T., Muller, C. P., Pallasch, C. P., Wunderlich, F. T., Waisman, A. and Hoevelmeyer, N. (2018). Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-kappa B signaling. Leukemia, 32 (1). S. 72 - 83. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Huelsemann, M., Baatout, D., Kintzele, L., Becker, H. J., Theurich, S., von Berwelt-Baildon, M., Pallasch, C. P., Hallek, M., Wendtner, C. M. and Frenzel, L. P. (2014). HYPOXIA - A CENTRAL MICROENVIRONMENTAL DETERMINANT OF PROLIFERATION AND DRUG-RESISTANCE OF PRIMARY CLL CELLS. Haematologica, 99. S. 39 - 41. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Huelsemann, M. F., Patz, M., Beckmann, L., Brinkmann, K., Otto, T., Fandrey, J., Becker, H. J., Theurich, S., von Bergwelt-Baildon, M., Pallasch, C. P., Zahedi, R. P., Kashkar, H., Reinhardt, H. C., Hallek, M., Wendtner, C. M. and Frenzel, L. P. (2015). Hypoxia-induced p38 MAPK activation reduces Mcl-1 expression and facilitates sensitivity towards BH3 mimetics in chronic lymphocytic leukemia. Leukemia, 29 (4). S. 981 - 985. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Huelsemann, M. F., Patz, M., Beckmann, L., Brinkmann, K., Otto, T., Fandrey, J., Becker, H. J., Theurich, S., von Bergwelt-Baildon, M., Pallasch, C. P., Zahedi, R. P., Kashkar, H., Reinhardt, H. C., Hallek, M., Wendtner, C. M. and Frenzel, L. P. (2015). Hypoxia-induced p38 MAPK activation reduces Mcl-1 expression and facilitates sensitivity towards BH3 mimetics in chronic lymphocytic leukemia. Leukemia, 29 (4). S. 981 - 985. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Nickel, N., Al-Maarri, M., Pal, M., Roth, A., Schaefer, S., Buettner, R., Hallek, M., Wunderlich, T. and Pallasch, C. P. (2016). AKT activation in Chronic Lymphocytic Leukemia cells promotes transformation towards aggressive Richter's syndrome lymphoma. Oncol. Res. Treat., 39. S. 13 - 14. BASEL: KARGER. ISSN 2296-5262
Nickel, N., Roth, A. and Pallasch, C. P. (2015). CHARACTERIZATION OF THE DNA-DAMAGE RESPONSE DOWNSTREAM OF B-CELL RECEPTOR SIGNALING IN CLL. Haematologica, 100. S. 413 - 414. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Schwamb, J., Reinart, N., Vorholt, D., Ristovska, V, Ulas, T., Leskov, I, Braun, C., Hemann, M., Schultze, J. L., Hallek, M. and Pallasch, C. P. (2014). Phagocytic function of macrophages is impaired by CLL and high-grade lymphoma progression and can be highly effectively restored by chemo-immunotherapy. Oncol. Res. Treat., 37. S. 236 - 238. BASEL: KARGER. ISSN 2296-5262
Thomalla, D., Beckmann, L., Grimm, C., Oliverio, M., Meder, L., Herling, C. D., Nieper, P., Feldmann, T., Merkel, O., Lorsy, E., Guerreiro, A. da Palma, von Jan, J., Kisis, I., Wasserburger, E., Claasen, J., Faitschuk-Meyer, E., Altmueller, J., Nuernberg, P., Yang, T. -P., Lienhard, M., Herwig, R., Kreuzer, K. -A., Pallasch, C. P., Buettner, R., Schaefer, S. C., Hartley, J., Abken, H., Peifer, M., Kashkar, H., Knittel, G., Eichhorst, B., Ullrich, R. T., Herling, M., Reinhardt, H. C., Hallek, M., Schweiger, M. R. and Frenzel, L. P. (2022). Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies. Blood, 140 (20). S. 2113 - 2127. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020